Cited by 36Urticaria and Related ConditionsPsychosomatic Disorders and Their TreatmentsDermatology and Skin Diseases

A Meta-Analysis of Observational Studies on the Association of Chronic Urticaria With Symptoms of Depression and Anxiety

Open access
Huang, Yuzhou, Xiao, Yi, Zhang, Xingyu, Li, Jie, Chen, Xiang, Shen, Minxue·2020·Frontiers in Medicine

Abstract

Background: Chronic urticaria (CU) is a frequently occurring skin condition associated with many psychological factors, but the effect size of associations varied in literature. Objectives: To perform a systematic review and meta-analysis on the associations of CU with symptoms of depression and anxiety. Methods:Using a prespecified protocol, we systematically searched articles published in PubMed, Web of Science, CNKI and CQVIP databases between January 2000 and January 2019. Pooled estimates in terms of odds ratios (ORs) and standardized mean differences (SMDs) were calculated according to outcome measures. Subgroup analysis by disease subtypes and tool of measurement, and sensitivity analysis were performed. Risk of bias and quality of studies were evaluated. Results: Twelve studies were selected for systematic review. The ORs were 3.99 (95%CI: 3.24 to 4.91, P<0.001) for anxiety and 2.94 (95%CI: 2.42–3.58, P<0.001) for depression. The SMDs of severity were 0.98 for anxiety (95%CI: 0.76–1.200, P<0.001), and 0.84 for depression (95%CI: 0.59–1.10, P<0.001). Subgroup assessment by disease subtypes and tool of measurement showed variations in effect size, where chronic spontaneous urticaria showed greater effects on anxiety (OR=6.62, 95%CI: 3.67–11.95, P<0.001), and depression (OR=6.13, 95%CI: 2.31–16.31, P<0.001). Sensitivity analysis demonstrated consistent results. Conclusion: CU is associated with two- to three-fold risks of anxiety and depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2020.00039

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Psychotropic drugs could have a positive effect on CSU treatment.

    “Psychotropic drugs (e.g., antidepressants and benzodiazepines) could have a positive effect on CSU treatment 11,31 .”

    From Could distress tolerance levels be associated with the severity of chronic spontaneous urticaria? (2022) · cites this paper as [11]

    The Introduction and Discussion (page numbers unavailable) address psychiatric comorbidity and the association of CSU with anxiety and depression, but do not address whether psychotropic drugs improve CSU treatment. Searches for antidepressants, benzodiazepines, psychotropic drugs, and treatment found no passage supporting that effect. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. [1]Zuberbier T Aberer W Asero R Abdul Latiff AH Baker D Ballmer-Weber B. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. (2018) 73: 1393– 414. 10.1111/all.13397 29336054 · DOI
  2. [2]Bernstein JA Lang DM Khan DA Craig T Dreyfus D Hsieh F. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. (2014) 133: 1270– 7. 10.1016/j.jaci.2014.02.036 24766875 · DOI
  3. [3]Zuberbier T Balke M Worm M Edenharter G Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. (2010) 35: 869– 73. 10.1111/j.1365-2230.2010.03840.x 20456386 · DOI
  4. [4]Magerl M Altrichter S Borzova E Gimenez-Arnau A Grattan CE Lawlor F. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. (2016) 71: 780– 802. 10.1111/all.12884 26991006 · DOI
  5. [5]Gupta MA Gupta AK. Psychodermatology: an update. J Am Acad Dermatol. (1996) 34: 1030– 46. 10.1016/S0190-9622(96)90284-4 8647969 · DOI
  6. [6]Picardi A Abeni D Melchi CF Puddu P Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. (2000) 143: 983– 91. 10.1046/j.1365-2133.2000.03831.x 11069507 · DOI · Paper page
  7. [8]Dalgard FJ Gieler U Tomas-Aragones L Lien L Poot F Jemec GBE. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. (2015) 135: 984– 91. 10.1038/jid.2014.530 25521458 PMC4378256 · DOI · Paper page
  8. [9]Tey HL Wallengren J Yosipovitch G. Psychosomatic factors in pruritus. Clin Dermatol. (2013) 31: 31– 40. 10.1016/j.clindermatol.2011.11.004 23245971 PMC3690364 · DOI
  9. [10]Hashiro M Okumura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci. (1994) 8: 129– 35. 10.1016/0923-1811(94)90007-8 7841156 · DOI
  10. [11]Staubach P Eckhardt-Henn A Dechene M Vonend A Metz M Magerl M. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. (2006) 154: 294– 8. 10.1111/j.1365-2133.2005.06976.x 16433799 · DOI · Paper page
  11. [12]Gupta MA Gupta AK Schork NJ Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. (1994) 56: 36– 40. 10.1097/00006842-199401000-00005 8197313 · DOI
  12. [13]Berrino AM Voltolini S Fiaschi D Pellegrini S Bignardi D Minale P. Chronic urticaria: importance of a medical-psychological approach. Eur Ann Allergy Clin Immunol. (2006) 38: 149– 52. 17058846
  13. [15]Dalgard FJ Svensson A Gieler U Tomas-Aragones L Lien L Poot F. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol. (2018) 179: 464– 70. 10.1111/bjd.16250 29247454 · DOI
  14. [17]Higgins JP Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. (2002) 21: 1539– 58. 10.1002/sim.1186 12111919 · DOI · Paper page
  15. [18]Egger M Davey Smith G Schneider M Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315: 629– 34. 10.1136/bmj.315.7109.629 9310563 PMC2127453 · DOI · Paper page
  16. [19]Wu YP Chang JM Fu Y Bao YQ Feng HP Yang M Study on the correlation between depression, anxiety and chronic urticaria. Chin J Dermatol. (2003) 36: 30– 2. 10.3760/j.issn:0412-4030.2003.02.009 · DOI
  17. [20]Pasaoglu G Bavbek S Tugcu H Abadoglu O Misirligil Z. Psychological status of patients with chronic urticaria. J Dermatol. (2006) 33: 765– 71. 10.1111/j.1346-8138.2006.00178.x 17073991 · DOI
  18. [21]Brzoza Z Kasperska-Zajac A Badura-Brzoza K Matysiakiewicz J Hese RT Rogala B. Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress. Psychosom Med. (2008) 70: 723– 8. 10.1097/PSY.0b013e31817bcc8d 18606731 · DOI
  19. [22]Engin B Uguz F Yilmaz E Ozdemir M Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. (2008) 22: 36– 40. 10.1111/j.1468-3083.2007.02324.x 18181971 · DOI
  20. [23]Uguz F Engin B Yilmaz E. Axis I and axis II diagnoses in patients with chronic idiopathic urticaria. J Psychosom Res. (2008) 64: 225– 9. 10.1016/j.jpsychores.2007.08.006 18222137 · DOI
  21. [24]Herguner S Kilic G Karakoc S Tamay Z Tuzun U Guler N. Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. Br J Dermatol. (2011) 164: 1342– 7. 10.1111/j.1365-2133.2010.10138.x 21083542 · DOI · Paper page
  22. [25]Zhang QL Hou SC Investigation on the correlation between artificial urticaria and depressive symptoms. J Clin Dermatol. (2011) 40: 475– 6. 10.3969/j.issn.1000-4963.2011.08.011 · DOI
  23. [26]Balp MM Vietri J Tian H Isherwood G. The impact of chronic urticaria from the patient's perspective: a survey in five European countries. Patient. (2015) 8: 551– 8. 10.1007/s40271-015-0145-9 26476961 PMC4662955 · DOI
  24. [28]Ograczyk A Miniszewska J Pietrzak A Zalewska-Janowska A. Sense of coherence as a protective factor in chronic urticaria. Postepy Dermatol Alergol. (2017) 34: 168– 73. 10.5114/ada.2017.67084 28507497 PMC5420610 · DOI
  25. [29]Tat TS. Higher levels of depression and anxiety in patients with chronic urticaria. Med Sci Monit. (2019) 25: 115– 20. 10.12659/MSM.912362 30609422 PMC6329254 · DOI
  26. [30]Balp MM Lopes da Silva N Vietri J Tian H Ensina LF The burden of chronic urticaria from Brazilian patients' perspective. Dermatol Ther. (2017) 7: 535– 45. 10.1007/s13555-017-0191-4 PMC5698196 28748405 · DOI
  27. [31]Barbosa F Freitas J Barbosa A. Chronic idiopathic urticaria and anxiety symptoms. J Health Psychol. (2011) 16: 1038– 47. 10.1177/1359105311398682 21459916 · DOI · Paper page
  28. [32]Georgin-Lavialle S Moura D Salvador A Chauvet-Gelinier J Launay J Damaj G. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. Mol Psychiatry. (2016) 21: 1511– 6. 10.1038/mp.2015.216 26809839 · DOI
  29. [33]Nautiyal KM Ribeiro AC Pfaff DW Silver R. Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci USA. (2008) 105: 18053– 7. 10.1073/pnas.0809479105 19004805 PMC2584714 · DOI
  30. [34]Yuan HP Li Z Zhang Y Li XP Li FK Li YQ. Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia. Int J Clin Exp Med. (2015) 8: 8010– 4. 26221363 PMC4509308
  31. [35]Theoharides TC Alysandratos KD Angelidou A Delivanis DA Sismanopoulos N Zhang B. Mast cells and inflammation. Biochim Biophys Acta. (2012) 1822: 21– 33. 10.1016/j.bbadis.2010.12.014 21185371 PMC3318920 · DOI
  32. [36]Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. (2009) 29: 247– 64. 10.1016/j.iac.2009.02.002 19389580 PMC2740752 · DOI · Paper page
  33. [37]Dowlati Y Herrmann N Swardfager W Liu H Sham L Reim EK. A meta-analysis of cytokines in major depression. Biol Psychiatry. (2010) 67: 446– 57. 10.1016/j.biopsych.2009.09.033 20015486 · DOI · Paper page
  34. [38]Liu Y Ho RC Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. (2012) 139: 230– 9. 10.1016/j.jad.2011.08.003 21872339 · DOI · Paper page
  35. [39]Conti P Caraffa A Ronconi G Conti C Kritas S Mastrangelo F. Impact of mast cells in depression disorder: inhibitory effect of IL-37. Immunol. Res. (2018) 66: 323. 10.1007/s12026-018-9004-9 29907890 · DOI
  36. [40]Weller K Koti I Makris M Maurer M. Anxiety and depression seem less common in patients with autoreactive chronic spontaneous urticaria. Clin Exp Dermatol. (2013) 38: 870– 3. 10.1111/ced.12190 23889120 · DOI
  37. [41]Zigmond AS Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. (1983) 67: 361– 70. 10.1111/j.1600-0447.1983.tb09716.x 6880820 · DOI · Paper page
  38. [43]Williams JW Jr Pignone M Ramirez G Perez Stellato C. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry. (2002) 24: 225– 37. 10.1016/S0163-8343(02)00195-0 12100833 · DOI
  39. [45]Coyne JC van Sonderen E. No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS). J Psychosom Res. (2012) 72: 173– 4. 10.1016/j.jpsychores.2011.12.003 22325694 · DOI · Paper page
  40. [46]Zung WW. A rating instrument for anxiety disorders. Psychosomatics. (1971) 12: 371– 9. 10.1016/S0033-3182(71)71479-0 5172928 · DOI · Paper page
  41. [47]Samakouri M Bouhos G Kadoglou M Giantzelidou A Tsolaki K Livaditis M. [Standardization of the Greek version of Zung's Self-rating Anxiety Scale (SAS)]. Psychiatriki. (2012) 23: 212– 20. 23073544
  42. [48]Zung WW. A self-rating depression scale. Arch Gen Psychiatry. (1965) 12: 63– 70. 10.1001/archpsyc.1965.01720310065008 14221692 · DOI · Paper page
  43. [49]Knight RG Waal-Manning HJ Spears GF. Some norms and reliability data for the State–Trait Anxiety Inventory and the Zung Self-Rating Depression scale. Br J Clin Psychol. (1983) 22: 245– 9. 10.1111/j.2044-8260.1983.tb00610.x 6640176 · DOI · Paper page
  44. [50]Newmann JP Engel RJ Jensen JE. Age differences in depressive symptom experiences. J Gerontol. (1991) 46: P224– 35. 10.1093/geronj/46.5.P224 1890289 · DOI
  45. [51]Tennen H Hall JA Affleck G. Depression research methodologies in the Journal of Personality and Social Psychology: a review and critique. J Pers Soc Psychol. (1995) 68: 870– 84; discussion 885–91. 10.1037/0022-3514.68.5.870 7776184 · DOI

Cited by

Sorted by citations

Authors
Huang, Y., Xiao, Y., Zhang, X., Li, J., Chen, X., & Shen, M.
Affiliations
Central South University (CN)
Corresponding author
  • Li, Jie
  • Chen, Xiang
  • Shen, Minxue
Venue
Frontiers in Medicine
Published
2020-02-27
Volume
7
Pages
39-39
ISSN
2296-858X (ISSN-L)
OpenAlex
W3007904794
Cited by
36
References
4
Citations by year
2026: 6 · 2025: 6 · 2024: 9 · 2023: 7 · 2022: 3 · 2021: 3 · 2020: 2
FWCI
0.58
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81974476, 81673065)
Topics
  • Health Sciences › Medicine › Rheumatology › Urticaria and Related Conditions
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
chronic urticaria, depression, anxiety, psychological comorbidity, chronic spontaneous urticaria, disease severity, mental health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review